CTLA4 and neoplasm: In addition to co‐stimulation inhibition, CTLA‐4 blockade also attenuates regulatory T‐cell (Treg) recruitment to the tumour site, leading to improved infiltration of tumour‐infiltrating lymphocytes (TILs).5